Federica Porcaro1, Giovanni Corsello2, Giovanni Battista Pajno3. 1. Respiratory Unit, Pediatric Pulmonology & Respiratory Intermediate Care Unit, Sleep and Long Term Ventilation Unit, Academic Department of Pediatrics, Bambino Gesù Children's Hospital, Piazza S. Onofrio 4, 00165, Rome, Italy. federica.porcaro@opbg.net. 2. Neonatal Intensive Care Unit, A.O.U.P. "P. Giaccone", Department of Sciences for Health Promotion and Mother and Child Care "G. D'Alessandro", University of Palermo, Via Alfonso Giordano n. 3, 90127, Palermo, Italy. 3. Allergy Unit, Department of Pediatrics, University of Messina, Messina, Italy.
Abstract
PURPOSE OF REVIEW: The progression of atopic disorders from atopic dermatitis in infants to allergic rhinitis and asthma in children, adolescents, and adults defines the allergy march. Allergen immunotherapy is the only causal treatment altering the immunological mechanism underlying the allergic diseases. The sublingual administration route is more acceptable than the subcutaneous one in pediatric age. RECENT FINDINGS: Several studies show the efficacy and safety profile of sublingual immunotherapy (SLIT) for the treatment of respiratory allergy diseases, but few data are available on its effect of primary and secondary prevention of allergic disease. The purpose of this manuscript is to review the latest studies addressing the effect of SLIT on the development of new sensitizations in not sensitized or already sensitized patients and progression of the allergy march.
PURPOSE OF REVIEW: The progression of atopic disorders from atopic dermatitis in infants to allergic rhinitis and asthma in children, adolescents, and adults defines the allergy march. Allergen immunotherapy is the only causal treatment altering the immunological mechanism underlying the allergic diseases. The sublingual administration route is more acceptable than the subcutaneous one in pediatric age. RECENT FINDINGS: Several studies show the efficacy and safety profile of sublingual immunotherapy (SLIT) for the treatment of respiratory allergy diseases, but few data are available on its effect of primary and secondary prevention of allergic disease. The purpose of this manuscript is to review the latest studies addressing the effect of SLIT on the development of new sensitizations in not sensitized or already sensitized patients and progression of the allergy march.
Authors: G Walter Canonica; Jean Bousquet; Thomas Casale; Richard F Lockey; Carlos E Baena-Cagnani; Ruby Pawankar; Paul C Potter; Philippe J Bousquet; Linda S Cox; Stephen R Durham; Harold S Nelson; Giovanni Passalacqua; Dermot P Ryan; Jan L Brozek; Enrico Compalati; Ronald Dahl; Luis Delgado; Roy Gerth van Wijk; Richard G Gower; Dennis K Ledford; Nelson Rosario Filho; Erkka J Valovirta; Osman M Yusuf; Torsten Zuberbier; Wahiduzzaman Akhanda; Raul Castro Almarales; Ignacio Ansotegui; Floriano Bonifazi; Jan Ceuppens; Tomás Chivato; Darina Dimova; Diana Dumitrascu; Luigi Fontana; Constance H Katelaris; Ranbir Kaulsay; Piotr Kuna; Dèsirée Larenas-Linnemann; Manolis Manoussakis; Kristof Nekam; Carlos Nunes; Robyn O'Hehir; José M Olaguibel; Nerin Bahceciler Onder; Jung Won Park; Alfred Priftanji; Robert Puy; Luis Sarmiento; Glenis Scadding; Peter Schmid-Grendelmeier; Ester Seberova; Revaz Sepiashvili; Dirceu Solé; Alkis Togias; Carlo Tomino; Elina Toskala; Hugo Van Beever; Stefan Vieths Journal: Allergy Date: 2009-12 Impact factor: 13.146
Authors: Zaraquiza Zolkipli; Graham Roberts; Victoria Cornelius; Bernie Clayton; Sarah Pearson; Louise Michaelis; Ratko Djukanovic; Ramesh Kurukulaaratchy; S Hasan Arshad Journal: J Allergy Clin Immunol Date: 2015-06-12 Impact factor: 10.793
Authors: B E García; E González-Mancebo; D Barber; S Martín; A I Tabar; Alonso Ma D Díaz de Durana; S Garrido-Fernández; G Salcedo; P Rico; M Fernández-Rivas Journal: J Investig Allergol Clin Immunol Date: 2010 Impact factor: 4.333
Authors: Hendrik Nolte; Niran Amar; David I Bernstein; Bobby Q Lanier; Peter Creticos; Gary Berman; Amarjot Kaur; Jacques Hébert; Jennifer Maloney Journal: Ann Allergy Asthma Immunol Date: 2014-05-14 Impact factor: 6.347